# Lemaitre Vascular Inc: filings

LMAT · Nasdaq · CIK 1158895 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lmat.md) · [Financials](/companies/lmat/financials.md) · [Filings](/companies/lmat/filings.md) · [Insiders](/companies/lmat/insiders.md)

## Reports and events: 237 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1199, 8-K 138, SC 13G/A 61, 10-Q 53, 4/A 45, 144 44, 10-K 18, DEF 14A 18, SC 13G 18, SD 13, ARS 10, SCHEDULE 13G/A 8, 3 7, UPLOAD 6, 424B5 4, 8-K/A 4, CORRESP 4, S-8 4, 10-K/A 3, 10-Q/A 3, 5 3, DEFA14A 3, EFFECT 2, S-3 2, SCHEDULE 13G 2, PRE 14A 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 20:11 ET | [8-K](/filings/0001193125-26-422885.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-422885 |
| 2026-08-05 | 10:30 ET | [10-Q](/filings/0001193125-26-333762.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333762 |
| 2026-08-04 | 20:39 ET | [8-K](/filings/0001193125-26-332982.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332982 |
| 2026-06-05 | 23:41 ET | [8-K](/filings/0001193125-26-257978.md) | 5.07 Shareholder vote results | 0001193125-26-257978 |
| 2026-05-06 | 10:30 ET | [10-Q](/filings/0001193125-26-207500.md) | Quarterly report, period 2026-03-31 | 0001193125-26-207500 |
| 2026-05-05 | 20:34 ET | [8-K](/filings/0001193125-26-206578.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-206578 |
| 2026-04-14 | 11:33 ET | [DEF 14A](/filings/0001193125-26-153877.md) | Proxy statement, period 2026-04-13 | 0001193125-26-153877 |
| 2026-04-14 | 10:45 ET | [8-K](/filings/0001193125-26-153779.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001193125-26-153779 |
| 2026-02-26 | 12:01 ET | [10-K](/filings/0001193125-26-073360.md) | Annual report, period 2025-12-31 | 0001193125-26-073360 |
| 2026-02-25 | 21:54 ET | [8-K](/filings/0001193125-26-071954.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071954 |
| 2025-11-07 | 11:59 ET | [10-Q](/filings/0001193125-25-270981.md) | Quarterly report, period 2025-09-30 | 0001193125-25-270981 |
| 2025-11-07 | 02:00 ET | [8-K/A](/filings/0001193125-25-270458.md) | 5.07 Shareholder vote results | 0001193125-25-270458 |
| 2025-11-06 | 21:03 ET | [8-K](/filings/0001193125-25-269454.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269454 |
| 2025-08-06 | 10:06 ET | [10-Q](/filings/0001437749-25-024936.md) | Quarterly report, period 2025-06-30 | 0001437749-25-024936 |
| 2025-08-05 | 20:22 ET | [8-K](/filings/0001437749-25-024862.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-024862 |
| 2025-06-03 | 21:01 ET | [8-K](/filings/0001437749-25-019314.md) | 5.07 Shareholder vote results | 0001437749-25-019314 |
| 2025-05-08 | 20:02 ET | [10-Q](/filings/0001437749-25-015479.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015479 |
| 2025-05-01 | 20:09 ET | [8-K](/filings/0001437749-25-014093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-014093 |
| 2025-04-17 | 14:11 ET | [DEF 14A](/filings/0001437749-25-012238.md) | Proxy statement, period 2025-06-02 | 0001437749-25-012238 |
| 2025-02-28 | 17:47 ET | [10-K](/filings/0001437749-25-005637.md) | Annual report, period 2024-12-31 | 0001437749-25-005637 |
| 2025-02-27 | 21:40 ET | [8-K](/filings/0001437749-25-005495.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-005495 |
| 2025-02-13 | 14:00 ET | [8-K](/filings/0001437749-25-003679.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-003679 |
| 2024-12-19 | 21:05 ET | [8-K](/filings/0001104659-24-130155.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-130155 |
| 2024-12-17 | 11:31 ET | [8-K](/filings/0001104659-24-129159.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-129159 |
| 2024-12-16 | 12:20 ET | [8-K](/filings/0001104659-24-128674.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-128674 |
| 2024-11-08 | 16:31 ET | [10-Q](/filings/0001437749-24-034124.md) | Quarterly report, period 2024-09-30 | 0001437749-24-034124 |
| 2024-10-31 | 20:02 ET | [8-K](/filings/0001437749-24-032784.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-032784 |
| 2024-08-26 | 20:12 ET | [8-K](/filings/0001437749-24-027754.md) | 5.02 Departure or appointment of officers or directors | 0001437749-24-027754 |
| 2024-08-08 | 18:01 ET | [10-Q](/filings/0001437749-24-025466.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025466 |
| 2024-08-01 | 20:26 ET | [8-K](/filings/0001437749-24-024304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-024304 |
| 2024-06-03 | 20:21 ET | [8-K](/filings/0001437749-24-019032.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-24-019032 |
| 2024-05-10 | 15:26 ET | [10-Q](/filings/0001437749-24-015899.md) | Quarterly report, period 2024-03-31 | 0001437749-24-015899 |
| 2024-05-02 | 20:13 ET | [8-K](/filings/0001437749-24-014372.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-014372 |
| 2024-04-16 | 16:01 ET | [DEF 14A](/filings/0001437749-24-012147.md) | Proxy statement, period 2024-06-03 | 0001437749-24-012147 |
| 2024-02-29 | 18:34 ET | [10-K](/filings/0001437749-24-006037.md) | Annual report, period 2023-12-31 | 0001437749-24-006037 |
| 2024-02-27 | 22:01 ET | [8-K](/filings/0001437749-24-005732.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-005732 |
| 2023-11-07 | 19:56 ET | [10-Q](/filings/0001437749-23-030613.md) | Quarterly report, period 2023-09-30 | 0001437749-23-030613 |
| 2023-11-01 | 20:47 ET | [8-K](/filings/0001437749-23-029792.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-029792 |
| 2023-08-08 | 16:56 ET | [10-Q](/filings/0001437749-23-022476.md) | Quarterly report, period 2023-06-30 | 0001437749-23-022476 |
| 2023-08-01 | 20:21 ET | [8-K](/filings/0001437749-23-021414.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-021414 |
| 2023-06-06 | 10:02 ET | [8-K](/filings/0001437749-23-016676.md) | 5.07 Shareholder vote results | 0001437749-23-016676 |
| 2023-05-09 | 20:28 ET | [10-Q](/filings/0001437749-23-013314.md) | Quarterly report, period 2023-03-31 | 0001437749-23-013314 |
| 2023-05-02 | 20:28 ET | [8-K](/filings/0001437749-23-012106.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-012106 |
| 2023-04-14 | 12:30 ET | [DEF 14A](/filings/0001437749-23-010217.md) | Proxy statement | 0001437749-23-010217 |
| 2023-03-01 | 18:06 ET | [10-K](/filings/0001437749-23-005056.md) | Annual report, period 2022-12-31 | 0001437749-23-005056 |
| 2023-02-23 | 20:51 ET | [8-K](/filings/0001437749-23-004378.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-004378 |
| 2022-11-08 | 21:34 ET | [10-Q](/filings/0001437749-22-026383.md) | Quarterly report, period 2022-09-30 | 0001437749-22-026383 |
| 2022-10-27 | 20:34 ET | [8-K](/filings/0001437749-22-024955.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-22-024955 |
| 2022-09-23 | 12:30 ET | [8-K](/filings/0001437749-22-022937.md) | 5.02 Departure or appointment of officers or directors | 0001437749-22-022937 |
| 2022-08-05 | 10:10 ET | [10-Q](/filings/0001437749-22-019001.md) | Quarterly report, period 2022-06-30 | 0001437749-22-019001 |

Page 1 of 5. [Older](/companies/lmat/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.